Cystic brain metastases (CBM) are a particular variant that have been reported in association with ALK-rearranged NSCLC [14–16] and may represent a diagnostic and therapeutic challenge in this clinical setting. The gene discussed is ALK; the disease is non-small cell lung carcinoma.